Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Regulation of lipid absorption by enterocytes can influence metabolic status in humans and contribute to
obesity
and related complications. The intracellular steps of chylomicron biogenesis and transport from the Endoplasmic Reticulum (ER) to the Golgi complex have been described, but the mechanisms for post-Golgi transport and secretion of chylomicrons have not been identified. Using a newly generated Dennd5b
-/-
mouse, we demonstrate an essential role for this gene in Golgi to plasma membrane transport of chylomicron secretory vesicles. In mice, loss of Dennd5b results in resistance to western diet induced
obesity
, changes in plasma lipids, and reduced aortic atherosclerosis. In humans, two independent exome sequencing studies reveal that a common
DENND5B
variant, p.(R52K), is correlated with body mass index. These studies establish an important role for
DENND5B
in post-Golgi chylomicron secretion and a subsequent influence on body composition and peripheral lipoprotein metabolism.
...
PMID:DENND5B Regulates Intestinal Triglyceride Absorption and Body Mass. 3083 51